Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SOPHIA GENETICS SA

(SOPH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sophia Genetics : Shares Drop in Nasdaq Debut

07/23/2021 | 02:17pm EDT


© MT Newswires 2021
All news about SOPHIA GENETICS SA
09/09SOPHIA GENETICS : Q2 Adjusted Loss Widens, Revenue Rises
MT
09/09SOPHIA GENETICS : Reports Second Quarter 2021 Financial Results and Issues 2021 ..
AQ
09/09Sophia Genetics Sa Announces Earnings Result for the Three Months and Six Mon..
CI
09/09Sophia Genetics Sa Provides Earnings Outlook for the Full Year 2021
CI
08/30SOPHIA GENETICS : to Present at the Morgan Stanley 19th Annual Global Healthcare..
AQ
08/26UPDATE – SOPHiA GENETICS to Report Second Quarter 2021 Financial Result..
GL
08/26SOPHIA GENETICS : to Report Second Quarter 2021 Financial Results on September 9..
AQ
08/24SOPHIA GENETICS : Dasa expands partnership with SOPHiA GENETICS for the first de..
PR
08/24Dasa Expands Partnership with SOPHiA GENETICS for the First Decentralized Can..
CI
08/17SOPHIA GENETICS : Credit Suisse Starts SOPHiA GENETICS at Outperform with $22 Pr..
MT
More news
Analyst Recommendations on SOPHIA GENETICS SA
More recommendations
Financials (USD)
Sales 2021 40,2 M - -
Net income 2021 -72,5 M - -
Net cash 2021 265 M - -
P/E ratio 2021 -13,3x
Yield 2021 -
Capitalization 1 123 M 1 123 M -
EV / Sales 2021 21,3x
EV / Sales 2022 18,0x
Nbr of Employees 415
Free-Float 95,7%
Chart SOPHIA GENETICS SA
Duration : Period :
SOPHiA GENETICS SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SOPHIA GENETICS SA
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 17,28 $
Average target price 23,00 $
Spread / Average Target 33,1%
EPS Revisions
Managers and Directors
Jurgi Camblong Chief Executive Officer & Director
Ross Muken Chief Financial Officer
Troy Cox Chairman
Zhenyu Xu Chief Scientific Officer & Senior Vice President
Philippe Menu Chief Medical Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
SOPHIA GENETICS SA0.00%1 123
SARTORIUS AG93.04%50 024
BIOTAGE AB (PUBL)80.58%1 908
REVENIO GROUP OYJ20.38%1 901
CELLAVISION AB (PUBL)42.22%1 214
VAREX IMAGING CORPORATION74.40%1 147